RecruitingNCT07558174

SPECTATOR: Perfusion Monitoring Before, During and After Lower Extremity Revascularization With Laser Speckle Contrast Imaging


Sponsor

Leiden University Medical Center

Enrollment

30 participants

Start Date

May 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to evaluate the feasibility of LSCI for perioperative perfusion assessment of the lower extremity before, during, and after revascularization.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Scheduled for lower-extremity revascularization
  • Undergoing pre- and postoperative ICG NIR fluorescence perfusion measurements

Exclusion Criteria1

  • Any condition that the investigator considers to be potentially jeopardizing the patient's wellbeing or the study objectives

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTLaser Speckle Contrast Imaging

Measurement with LSCI device


Locations(1)

Leiden University Medical Center

Leiden, South Holland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07558174


Related Trials